Cargando…
Role of Immunomodulation of BCG Therapy on AML Remission
Bacillus Calmette–Guérin (BCG) has been studied in various cancers for its immune modulation. Although the mechanism is yet to be completely understood, we do have positive experiences in many oncological cases. Hereby, we present a case of an 82-year-old male with acute myeloid leukemia (AML) post...
Autores principales: | Kennedy, Alice, Sahu, Kamal Kant, Cerny, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920581/ https://www.ncbi.nlm.nih.gov/pubmed/33658865 http://dx.doi.org/10.2147/IMCRJ.S296387 |
Ejemplares similares
-
A Splenic Infarction Related to Parainfluenza Infection in a Patient with AML: Lessons for COVID-19
por: Vogt, Bennett E, et al.
Publicado: (2021) -
Spontaneous remission in three cases of AML M5 with NPM1 mutation
por: Camus, Vincent, et al.
Publicado: (2015) -
Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML
por: Vachhani, Pankit, et al.
Publicado: (2016) -
BCG Aortitis, a Rare Complication of BCG Therapy
por: Haddad, Joseph, et al.
Publicado: (2023) -
BCG immunomodulation: From the ‘hygiene hypothesis’ to COVID-19
por: Moulson, Aaron J., et al.
Publicado: (2021)